Skip to main content
EMV CAPITAL PLC logo

EMV CAPITAL PLC — Investor Relations & Filings

Ticker · EMVC ISIN · GB00BN4R5Q82 LEI · 213800N5WD46G1Y7I458 IL Financial and insurance activities
Filings indexed 547 across all filing types
Latest filing 2017-05-25 Capital/Financing Update
Country GB United Kingdom
Listing IL EMVC

About EMV CAPITAL PLC

https://www.emvcapital.com/

EMV Capital PLC is a venture capital investment group specializing in deep tech and life sciences. The firm identifies, invests in, and builds high-growth, IP-rich companies with an international portfolio, focusing on sectors including industrial technology, healthcare, and sustainability. It employs a capital-efficient investment strategy that combines syndicated investments, direct balance sheet funding, and managed funds to support companies from their early stages through to successful exit. EMV Capital engages in proactive portfolio management, often taking board positions and working closely with company leadership. It provides extensive value creation services, including support for fundraising, exit readiness, IP strategy, and corporate collaborations, to drive growth and maximize returns for investors through strategic exits.

Recent filings

Filing Released Lang Actions
Proposed Placing and Subscription
Capital/Financing Update Classification · 95% confidence The document is an announcement by NetScientific PLC regarding a proposed capital raise (placing and subscription) and a notice of a General Meeting to approve the issuance of new shares. While it mentions a General Meeting, the primary purpose of the document is to announce the financing activity and the capital structure change (issuing new shares). This fits the definition of a Capital/Financing Update (CAP) and a Share Issue/Capital Change (SHA). Given the primary focus on the fundraising event and the associated share issuance, 'CAP' is the most accurate classification for this type of corporate finance announcement.
2017-05-25 English
Vortex Initiates Clinical Research Studies
Regulatory Filings Classification · 98% confidence The document is a press release issued via the London Stock Exchange's Regulatory News Service (RNS). It announces that a portfolio company, Vortex Biosciences, has initiated clinical research studies. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a corporate governance or shareholder meeting document. As it is a general regulatory announcement regarding company operations and news, it falls under the RNS category.
2017-05-24 English
ProAxsis announces additional IP
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from NetScientific PLC regarding a licensing agreement secured by its portfolio company, ProAxsis. It details business developments, intellectual property acquisition, and strategic partnerships. Since it is a general corporate announcement that does not fit into specific categories like financial reports, M&A, or director dealings, it falls under the RNS (Regulatory Filings) category.
2017-05-10 English
ProAxsis Presents New Data at Major US Conference
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from the London Stock Exchange regarding a portfolio company's upcoming conference presentation. It does not fit into specific categories like financial reports, dividends, or governance. As it is a general corporate announcement that does not fall into the other defined categories, it is classified as a Regulatory Filing (RNS).
2017-05-05 English
BTG purchases Wanda's shares in Oncoverse
Regulatory Filings Classification · 98% confidence The document is an announcement from NetScientific PLC regarding the sale of its portfolio company Wanda's holding in OncoVerse to BTG plc. This is a corporate announcement regarding M&A activity (divestiture/sale of an asset). It is distributed via the London Stock Exchange's RNS (Regulatory News Service) system. Since it details a specific transaction involving the sale of a business unit/asset, it falls under M&A Activity.
2017-04-24 English
Group of companies' accounts made up to 2016-12-31
Regulatory Filings
2017-04-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.